Rubella Vaccine

Rubella vaccine refers to active immunizing agents containing live attenuated rubella virus, predominantly administered as an antigenic component of combination vaccines such as measles, mumps, and rubella (MMR) or measles, mumps, rubella, and varicella (MMRV)

Rubella vaccine refers to active immunizing agents containing live attenuated rubella virus, predominantly administered as an antigenic component of combination vaccines such as measles, mumps, and rubella (MMR) or measles, mumps, rubella, and varicella (MMRV)

These biological agents function by stimulating a protective humoral and cell-mediated immune response, prompting the production of specific neutralizing antibodies against the rubella virus without inducing severe clinical illness

These biological agents function by stimulating a protective humoral and cell-mediated immune response, prompting the production of specific neutralizing antibodies against the rubella virus without inducing severe clinical illness

Their primary therapeutic role is the prevention of acquired rubella infection and, critically, the prevention of maternal-fetal transmission that causes congenital rubella syndrome (CRS), which can result in severe fetal demise, cardiac defects, cataracts, and sensorineural deafness

Their primary therapeutic role is the prevention of acquired rubella infection and, critically, the prevention of maternal-fetal transmission that causes congenital rubella syndrome (CRS), which can result in severe fetal demise, cardiac defects, cataracts, and sensorineural deafness

Their primary therapeutic role is the prevention of acquired rubella infection and, critically, the prevention of maternal-fetal transmission that causes congenital rubella syndrome (CRS), which can result in severe fetal demise, cardiac defects, cataracts, and sensorineural deafness